ABBV vs AMZN: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Amazon.com, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-18.
AbbVie Inc. · Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Amazon.com, Inc. · Consumer Cyclical
$251.19
+18.5% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
AMZN has more upside to fair value
(+18.5%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ABBV |
AMZN |
| Current Price |
$261.70 |
$251.19 |
| Fair Value Estimate |
$259.04 |
$297.67 |
| Upside to Fair Value |
-1.0%
|
+18.5%
|
| Market Cap |
$462.4B |
$2,702.1B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
11.2x
|
| Price / Sales |
7.2x
|
3.5x
|
| Price / FCF |
23.6x
|
—
|
| Revenue Growth YoY |
+10.2%
|
+19.6%
|
| Gross Margin |
71.5%
|
50.8%
|
| Operating Margin |
29.3%
|
12.1%
|
| Return on Equity |
-136.5%
|
30.5%
|
| Dividend Yield |
2.61% |
0% |
| FCF Yield |
4.25%
|
—
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset a…
Amazon.com operates a vast global retail enterprise spanning online and physical stores, third-party seller services, advertising, subscription offerings, and Amazon Web Services, the world's largest cloud infrastructure provider. The business quality is high: trailing-twelve-month gross margin of 50.8%, operating margin of 12.1%, and net margin of 17.4% reflect a durable mix shift toward high-ma…
Accumulation Zones
| Metric |
ABBV |
AMZN |
| Zone Low |
$194.28 |
$223.25 |
| Zone High |
$220.18 |
$253.02 |
| In Buy Zone? |
No
|
Yes
|